Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 4:00 pm Purchase |
2024-11-14 | 13D | Akari Therapeutics, Plc AKTX |
Patel Samir Rashmikant | 5,745,834,167 10.850% |
2,332,672,000 (+68.34%) |
Filing History |
| 2024-10-25 4:28 pm Purchase |
2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA |
Patel Samir Rashmikant | 2,466,377 5.800% |
2,466,377 (New Position) |
Filing History |
| 2024-06-07 6:00 pm Purchase |
2024-05-31 | 13D | Akari Therapeutics, Plc AKTX |
Patel Samir Rashmikant | 3,413,162,167 14.500% |
3,413,162,167 (New Position) |
Filing History |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Akari Therapeutics, Plc AKTX |
Patel Samir Rashmikant | 393,102 9.900% |
209,198 (+113.75%) |
Filing History |
| 2022-02-14 08:02 am Purchase |
2021-12-31 | 13G | Akari Therapeutics, Plc AKTX |
Patel Samir Rashmikant | 183,904 6.200% |
59,285 (+47.57%) |
Filing History |
| 2021-02-16 08:31 am Purchase |
2020-12-31 | 13G | Akari Therapeutics, Plc AKTX |
Patel Samir Rashmikant | 124,619 7.200% |
48,417 (+63.54%) |
Filing History |